We have compared the tyrosine kinase activity of pp60cs`isolated from intact chicken embryo fibroblasts treated with micromolar sodium orthovanadate for 4 h and from untreated cells. We found an approximate 50% reduction in both autophosphorylation of pp604-' and phosphorylation of casein when examined in the immune complex kinase assay. The reduction of in vitro enzymatic activity correlated with a vanadate-induced increase in in vivo phosphorylation of pp60`Csrc at the major site of tyrosine phosphorylation in the carboxyl-terminal half of the molecule and at serine in the amino-terminal half of the molecule. Our observations in vivo and those of Courtneidge in vitro (EMBO J. 4:1471(EMBO J. 4: -1477(EMBO J. 4: , 1985 Transformation of cells by Rous sarcoma virus (RSV) is correlated with an 8-to 10-fold increase in cellular phosphotyrosine (44) distributed among numerous cellular proteins (36). This increase is attributable to the expression of a functional (44), 60-kilodalton (kDa), virus-encoded (5, 38) cyclic AMP-independent (21), tyrosine-specific (12, 25, 33) protein kinase (pp60v-src). Several specific intracellular substrates for pp60v-src have been identified (for a review, see reference 24), although the role of tyrosine phosphorylation in transformation has not been elucidated. However, the consistent correlation between tyrosine phosphorylation and transformation indicates that expression of pp60v-src kinase activity is necessary for transformation (44).
phosphorylation in pp6Oc-S remains unclear. The 36-kilodalton phosphoprotein, a substrate of pp60v-src, showed a significant phosphorylation at tyrosine after treatment of normal chicken embryo fibroblasts with vanadate. Assuming that pp60`-Sl is inhibited intracellularly by vanadate, either another tyrosine kinase is stimulated by vanadate (e.g., a growth factor receptor) or the 36-kilodalton phosphoprotein in normal cells is no longer rapidly dephosphorylated by a tyrosine phosphatase in the presence of vanadate.
Transformation of cells by Rous sarcoma virus (RSV) is correlated with an 8-to 10-fold increase in cellular phosphotyrosine (44) distributed among numerous cellular proteins (36) . This increase is attributable to the expression of a functional (44) , 60-kilodalton (kDa), virus-encoded (5, 38) cyclic AMP-independent (21), tyrosine-specific (12, 25, 33) protein kinase (pp60v-src). Several specific intracellular substrates for pp60v-src have been identified (for a review, see reference 24) , although the role of tyrosine phosphorylation in transformation has not been elucidated. However, the consistent correlation between tyrosine phosphorylation and transformation indicates that expression of pp60v-src kinase activity is necessary for transformation (44) .
The primary structure of the normal cellular homolog of pp60v-src, pp604-src, is very similar but not identical to that of pp6jv-src* The 19 carboxyl-terminal amino acids of chicken pp60c-src are replaced by a new set of 12 amino acids at the carboxyl-terminal end of pp60v-src encoded by the SchmidtRuppin A strain RSV, and 8 additional amino acid substitutions are found throughout the pp60v-src molecule (48) . In the intact cell pp6&c-src and pp60v-src are each phosphorylated at a serine residue in the amino-terminal half of the molecule, serine 17 (11, 19, 46) , whereas pp6Ocsrc is phosphorylated in the carboxyl-terminal half of the molecule at a tyrosine residue distinct from tyrosine 416, which is phosphorylated in pp60v-src (10, 29, 45) . Recent studies have indicated that phosphorylation of pp6&-src in the intact cell occurs at tyrosine 527, located in the 19 carboxyl-terminal amino acids unique to pp6Ocsrc (14) .
Earlier experiments showed that although the range of exogenous substrates and other aspects of the in vitro tyrosine kinase activities of pp60c-src and pp6OV-src are similar, the specific activities of pp60csrc for exogenous substrates and autophosphorylation are lower than those of * Corresponding author. pp60v-src (18) . pp6O -,rc in normal cells occurs at a level 30 to 50 times lower than pp60vsrc in cells infected and transformed by RSV (10) . To test the hypothesis that cell transformation comes about as a result of a general overexpression of the src-related tyrosine kinase activity, pp6O-src was expressed in rodent fibroblasts at a level 7 to 10 times greater than the level of pp60v-src in RSV-transformed rodent fibroblasts. Only a limited focus-forming ability and minimal increases in total cellular phosphotyrosine and tyrosine phosphorylation of enolase and the 36-kDa phosphoprotein (intracellular substrates of pp60fvsrc [22, 24, 41] ) were observed (18, 27) . Additionally, these cells were not tumorigenic in vivo (27) . One explanation for these results would be that the intracellular tyrosine kinase activity of pp60csrc is restricted relative to that of pp60-src by an in vivo mechanism(s) (18, 27) .
A possible regulatory mechanism of pp6O-src and pp60c-src tyrosine kinase activity is the phosphorylation state of the molecules. Incubation of partially purified preparations of pp6Ov-src with Mg2+ and ATP (13, 40) , lysis of RSVtransformed cells in the presence of Mg2+ and ATP (9), incubation of intact RSV-transformed cells with vanadate (4, 9) , and incubation of plasma membrane fractions from RSV-transformed cells with Mg2+, ATP, and vanadate (43) facilitate the identification of hyperphosphorylated forms of pp6&v-src (at tyrosine residues in the amino-terminal half of the molecule) that are more enzymatically active. Recently, Courtneidge (17) showed that lysis of untransformed rodent cells in the presence of vanadate facilitates the recovery of a population of pp60'csrc that is hyperphosphorylated at the major tyrosine residue in the carboxyl-terminal half of the molecule (presumably tyrosine 527 [14] ). In contrast to hyperphosphorylated pp6Ovsrc, the in vitro kinase activity is depressed (17) . Conversely pp60-src bound to middle T antigen in polyomavirus-transformed cells exhibits enhanced tyrosine kinase activity in vitro (2, 6, 17) and is not detectably phosphorylated at tyrosine 527 (7) . Studies correlating 1140 RYDER AND GORDON phosphorylation at tyrosine 527 with a reduction in in vitro tyrosine kinase activity suggest a mechanism by which the tyrosine kinase activity of pp60c-src may be restricted. In our study, we incubated intact, untransformed chicken embryo fibroblasts (CEF) (30) . S. aureus-bound immune complexes were washed three times with ice-cold RIPA buffer and solubilized in SDS sample buffer (2% SDS-10% glycerol-5% 2-mercaptoethanol-2 mM EDTA-0.14 M Tris hydrochloride, pH 6.8) at 90°C for 3.5 min and analyzed by SDSpolyacrylamide gel electrophoresis (SDS-PAGE).
For immunoprecipitation of the 36-kDa phosphoprotein a specific rabbit antiserum kindly provided by S. Decker was employed (20 7, 1987 was then performed by the method of Cleveland et al. (8) with 5.0 ng of S. aureus V8 protease. Peptide fragments were resolved on a 12.5% separating gel, which was stained, dried, and exposed for autoradiography.
Tryptic peptide analysis. The procedure for tryptic peptide analysis was that of Karess and Hanafusa (29) , with the following exceptions. Tryptic peptides were dissolved in 10 ,U of distilled water and spotted onto 20-by 20-cm Eastman plastic-backed cellulose sheets. Ascending chromatography was performed with n-butanol-acetic acid-water-pyridine (75:15:60:60). The plates were dried, and the second dimension was resolved by electrophoresis in pyridine-acetic acidwater (100:3:879), pH 6.5, at 600 V for 60 min on a Pharmacia flat bed. 32P-labeled tryptic peptides were visualized by autoradiography with XAR-5 film and intensifying screens.
Phosphoamino acid analysis. Phosphoamino acids were analyzed by the methods of Cooper et al. (16) . Briefly, 32P-labeled protein bands of interest were excised from dried gels and hydrated with 20 to 40 ,ul of 0.1% SDS-5% 2-mercaptoethanol-10% glycerol-10 mM Tris hydrochloride (pH 6.8). Phosphoproteins were eluted with 0.1% SDS-5% 2-mercaptoethanol-50 mM NH4HCO3 (pH 8.0) and precipitated with 25% trichloroacetic acid; 50 ,ug of bovine serum albumin was used as a carrier. Precipitated protein was washed three times with a 1:1 mixture of ethanol and ether, dried, and suspended in 75 ,ul of 6.0 N HCl (Pierce Chemical Co.). Hydrolysis was carried out at 110°C for 75 min. The hydrolysates were dried, suspended in 4 ,ud of phosphoamino acid standard solution (2 mg each of phosphoserine, phosphothreonine, and phosphotyrosine per ml in 0.2% pyridine-2% acetic acid, pH 3.5) and spotted onto an Eastman plastic-backed cellulose, sheet. The plastic-backed cellulose sheet was wetted with 0.2% pyridine-2% acetic acid (pH 3.5), and electrophoresis was carried out at 500 V on a Pharmacia flat bed. The run length was judged by the migration of Sanger dyes (0.7% xylene cyanol, 1.3% orange G, 0.7% acid fuchsin). The phosphoamino acid standards were visualized after spraying with ninhydrin. Autoradiog- 28 h facilitates the recovery of a hyperphosphorylated population of pp6Ov-src that exhibits enhanced in vitro tyrosine kinase activity (4, 9) . To determine the effect of vanadate on pp60c-src from untransformed cells, confluent plates of CEF were incubated with or without micromolar vanadate for 2, 4, or 6 h, cells were lysed, pp60csrc was immunoprecipitated, and autophosphorylation activity was assayed in the immune complex. In contrast to the reported effect of vanadate on pp60v-src, we found an inhibition of pp60c.src specific activity assayed in vitro ( pp6Jc-src from control and vanadate-treated CEF was examined in immune complex kinase assays employing the exogenous substrate casein. The in vitro kinase activity of pp60"csrc from vanadate-treated cells was also inhibited when an exogenous substrate was used (Fig. 1B) . In this study, the phosphorylation of casein by pp60csrc from control cells was 2.26-fold greater than that by pp60"csrc from vanadate-treated cells. Phosphoamino acid analysis of the casein bands indicated that phosphorylation occurred almost exclusively at tyrosine (data not shown).
Inhibition of pp6Ocsrc kinase activity after lysis of untransformed rodent cells in the presence of vanadate has recently been reported (17) . We have repeatedly lysed CEF in the presence of 100 1xM vanadate and assayed pp60'csrc tyrosine kinase activity in the immune complex (autophosphorylation and casein). We observed no difference in the in vitro tyrosine kinase activity of pp60csrc from control CEF compared to pp60c-sc from CEF lysed in the presence of vanadate (data not shown). We conclude that the effect of vanadate is seen only with intact CEF. Similarly, lysis of RSV-transformed cells in the presence of vanadate has been reported to have no effect on the enzymatic activity of pp6Ov-src (4, 9) .
Comparison of the phosphorylation state of pp6oCS-r from control and vanadate-treated CEF. Enhancement of the tyrosine kinase activity of pp60v-src from vanadate-treated cells is correlated with the appearance of a structurally modified form of the enzyme containing phosphotyrosine in the 34-kDa amino-terminal peptide (4, 9) . To see whether inhibition of the kinase activity of pp60c-src from vanadatetreated cells correlated with a change in the phosphorylation state of the enzyme, CEF were incubated for 4 h with sodium [32P]orthophosphate with or without 50 ,uM vanadate. Cells were lysed, and pp60c-src was immunoprecipitated. Subsequent analysis of pp60csrc from these experiments showed a modest but reproducible increase in the total phosphate content of pp6Ocsrc from vanadate-treated cells compared with that in pp60csrc isolated from control cells (16 to 42% increase in nine independent experiments). Figure 2A is an autoradiogram of 32P-labeled pp60csrc from control and vanadate-treated cells. In this experiment, pp6c-src from vanadate-treated cells contained 19% more radiolabel.
The protein bands depicted in Fig. 2A were subjected to limited proteolysis with S. aureus V8 protease. Phosphorylation of pp60csrc from control and vanadate-treated cells occurred in the 26-kDa carboxyl-terminal peptide and in the 34-, 16-, and 18-kDa amino-terminal peptides (Fig. 2B) . Densitometric analysis of the autoradiogram in Fig. 2B (Fig.  2C) showed that there was increased phosphorylation of pp6c-src from vanadate-treated cells in both the amino-and carboxyl-terminal peptides. This finding was reproduced in four additional studies. Only phosphoserine was found in the amino-terminal peptides, and only phosphotyrosine was present in the carboxyl-terminal peptides, of pp60csrc from both control and vanadate-treated cells (Fig. 3) .
We Tryptic peptide analysis of pp6O-slc from control and vanadate-treated CEF. To determine whether increased phosphorylation of pp6fc-src induced by vanadate involved phosphorylation of novel amino acid residues, tryptic peptide analyses were performed. Figure 4 shows autoradiograms of 32P-labeled tryptic peptides of pp6Oc-src from control and vanadate-treated cells incubated with sodium [32P]orthophosphate. The major phosphorylated tryptic peptides of pp60csrc fom control and vanadate-treated cells are identical (in repetitions of this experiment, the small peptide between peptides 3 and 4 was variably present in both control and vanadate conditions); a mixing experiment confirmed this observation (data not shown). Phosphoamino acid analysis revealed phosphoserine in peptide 1, phosphotyrosine in peptides 2 and 3, and phosphoserine and phosphotyrosine in peptide 4 (data not shown). Presumably peptifle 4 is partially trypsinized or untrypsinized pp60csrc.
Two sites of tyrosine phosphorylation have been detected in the carboxyl-terminal 26 kDa of pp60c-src: tyrosine 416 (45), the site that is autophosphorylated in in vitro kinase reactions, and tyrosine 527, the site that is phosphorylated in the intact cell (14) . pp6Oc-src labeled with 32p in the intact cell and autophosphorylated pp60c-src were mixed and subjected to tryptic peptide analysis. Another 32P-labeled peptide in addition to those depicted in Fig. 4 peptide presumably contained tyrosine 416, then pp60c-src was only phosphorylated in vivo at tyrosine 527 in control and vanadate-treated cells.
Avian pp60c-src from untransformed cells treated with various tumor promoters is phosphorylated at serine 12 and serine 48 in addition to serine 17 and yields several phosphoserine-containing tryptic peptides in addition to those shown in Fig. 4 (23) . In the absence of any new 32P-labeled tryptic peptides in the vanadate condition, we conclude that the vanadate-induced increase in phosphorylation of pp6Ocsrc occurred at the two major sites of phosphorylation in untransformed CEF (serine 17 with MAb 327 and a secondary antibody ( Fig. 2A) , with the secondary antibody alone (data not shown), with a specific rabbit antiserum against the 36-kDa phosphoprotein, or with nonimmune rabbit serum (Fig. 5A) . The phosphorylation state of this 30-kDa molecule was enhanced, quite reproducibly, by vanadate treatment of CEF. Phosphoamino acid analysis of this protein from both control and vanadatetreated cells revealed only phosphoserine (data not shown). A 36-kDa phosphoprotein has been identified as an intracellular substrate of pp6Ov-src in RSV-transformed cells (22, 24, 41) . Increased tyrosine phosphorylation of this phosphoprotein also occurs when untransformed cells are treated with epidermal growth factor or platelet-derived growth factor (15, 42) . The 36-kDa phosphoprotein is only lightly phosphorylated at serine in untransformed CEF (26) . Since vanadate stimulated tyrosine phosphorylation of pp6Oc-src and since vanadate treatment of untransformed rodent cells has been reported to stimulate tyrosine phosphorylation of the 36-kDa phosphoprotein (31), we undertook studies to determine whether vanadate has a similar effect on the 36-kDa phosphoprotein in untransformed CEF. CEF were incubated with sodium [32P]orthophosphate with or without 50 ,uM sodium orthovanadate. Cells were lysed, and the 36-kDa phosphoprotein was immunoprecipitated. Vanadate treatment of CEF did enhance phosphorylation of this protein (74% in the study depicted in Fig. SA) , and the increased phosphorylation occurred predominantly at tyrosine (Fig.  SB) .
DISCUSSION
Recent experiments have shown that very high-level overexpression of pp6Oc-src in untransformed cells does not cause full cellular transformation or in vivo tumorigenicity. The cells can form small foci and show a modest increase in cellular protein phosphotyrosine. These studies suggest that the tyrosine kinase activity of pp6Oc-src may be limited in the intact cell (18, 27) .
In this paper we have presented studies showing that short-term incubation of intact CEF with added sodium orthovanadate results in the recovery of a population of pp60c-src that has decreased in vitro kinase activity. This decreased in vitro kinase activity correlates with an increase in in vivo tyrosine phosphorylation in the carboxyl-terminal half of the molecule and serine in the amino half of the molecule. Our findings concerning the effect of vanadate on pp60-csrc in intact cells are similar to those of Courtneidge, who reported that lysis of untransformed rodent cells in the presence of sodium orthovanadate facilitates recovery of pp60c-src that has decreased in vitro tyrosine kinase activity and is more heavily phosphorylated at tyrosine in the carboxyl-terminal half of the molecule (17) . Increased tyrosine phosphorylation induced by incubation of intact cells or lysis of cells in the presence of vanadate does not involve novel sites of phosphorylation and presumably occurs at tyrosine 527. Further evidence supporting the notion that phosphorylation-dephosphorylation events at tyrosine 527 regulate enzymatic activity stems from an observation that pp60c-src from polyomavirus-transformed cells bound to middle T antigen exhibits enhanced in vitro tyrosine kinase activity (2, 6, 17) and is not detectably phosphorylated at tyrosine 527 (7) . Increased phosphorylation at tyrosine in the carboxyl-terminal half of the molecule in vanadate-treated cells could result from inhibition of a tyrosine-specific phosphatase (47) , stimulation of a tyrosine-specific kinase, or alteration in the structure or location (or both) of pp60c-src. Phosphorylation at tyrosine 527 is peculiar to pp6Ocsrc, since this amino acid residue is located in the 19 carboxyl-terminal amino acids unique to pp60c-src (14, 48 pp60-src from intact RSV-transformed cells (4, 9) or from plasma membrane fractions (43) incubated with vanadate has hyperphosphorylated tyrosine in the amino-terminal half of the molecule. This hyperphosphorylated form of the molecule has increased tyrosine kinase activity both in vitro (4, 9) and in vivo (4) , in contrast to our findings with pp6Oc-rc. Tyrosine residues in the amino-terminal half of the molecule are apparently autophosphorylated (43) , suggesting that pp60v-src can enhance its own enzymatic activity. It is not known whether tyrosine 527 of pp6Ocsrc is autophosphorylated or phosphorylated by another tyrosine kinase. If phosphorylation at this residue inhibits the in vivo kinase activity of pp60c-src, and if this residue is autophosphorylated, then pp60c-src has the capacity to inhibit its own kinase activity. Alternatively, it has been suggested that regulation may relate to compartmentalization of pp6Oc-src (18) .
Recent studies have shown that pp6Oc-src is capable of autophosphorylating tyrosine in the amino-terminal half of the molecule in in vitro kinase assays when bound to middle T antigen from polyomavirus-transformed cells (6, 49) or when extracted from neuroblastoma cell lines (1). These hyperphosphorylated forms of pp60c-src may be found in vivo (1, 49) and are more active in in vitro kinase assays when exogenous substrates are employed (1, 2, 6 ). pp6Oc-src from quiescent murine fibroblasts that have been treated with platelet-derived growth factor is also phosphorylated at tyrosine in the amino-terminal half of the molecule and demonstrates enhanced in vitro kinase activity (42) . Although the phosphorylation state of tyrosine 527 in pp6Ocsrc from neuroblastoma cell lines and from platelet-derived growth factor-stimulated fibroblasts has not been investigated, tyrosine 527 in pp60csr bound to middle T antigen is not detectably phosphorylated (7) . If there is decreased phosphorylation of tyrosine 527 in the former two cases, then lack of phosphorylation at this site may enable pp6Oc-src to autophosphorylate tyrosine residues in the aminoterminal half of the molecule. Such autophosphorylation may simply be a reflection of enhanced tyrosine kinase activity, or it may serve to further stimulate tyrosine kinase activity as is apparently the case with pp6Ov-src (4, 9) . It would be of interest to know whether two recently identified single-amino-acid substitutions that enhance the tyrosine kinase activity and transforming potential of pp60c-src (34) somehow inhibit phosphorylation at tyrosine 527.
We also found increased phosphorylation at serine, prob- We found that lysis of normal CEF in the presence of vanadate has no effect on the tyrosine kinase activity or phosphorylation state of pp6Oc-sr. Additionally, lysis of RSV-transformed CEF and RSV-transformed vole cells has no effect on the phosphorylation state or tyrosine kinase activity of pp6v-src (4, 9) . Thus, it is not clear why lysis of the untransformed rodent cells used by Courtneidge in the presence of vanadate facilitates identification of a more highly phosphorylated, less active form of pp60c-src (17) . Perhaps these cells contain a phosphatase or kinase that is active and subject to modulation by vanadate in lysates.
Tyrosine phosphorylation of the 36-kDa phosphoprotein substrate of pp6Ov-src is less than expected in rodent cells containing very high levels of overexpressed pp6c-src (18, 27) and negligible in CEF overexpressing pp6Oc-src (26) . However, we found increased phosphorylation of this protein in untransformed CEF treated with vanadate; a similar observation has been made with untransformed rodent cells (31) . Intracellular substrates for pp6Oc-sr have not been identified, although in rodent fibroblasts treated with platelet-derived growth factor the appearance of pp6Oc-src phosphorylated at tyrosine in the amino-terminal half of the molecule is paralleled by an increase in tyrosine phosphorylation of the 36-kDa phosphoprotein, suggesting a possible relationship (42) . However, epidermal growth factor treatment of cells stimulates increased tyrosine phosphorylation of the 36-kDa phosphoprotein that is not paralleled by the appearance of structurally modified or more active form of pp6c-src (15) . These studies suggest that although pp6Oc-src may phosphorylate the 36-kDa phosphoprotein in normal cells, it may not be the only tyrosine kinase activity that is capable of doing so. Regardless of which tyrosine kinase phosphorylates the 36-kDa phosphoprotein, such phosphorylation may be transient and kept at low and even undetectable levels presumably by phosphotyrosyl phosphatases. Inhibition of these phosphatases may well lead to a net (and observable) increase in tyrosine phosphorylation of the 36-kDa phosphoprotein even if the responsible kinase is inhibited.
Finally, a recent report suggested that increased intracellular tyrosine phosphorylation after vanadate treatment of untransformed rodent cells leads to transformation as evidenced by cell rounding, modest increase in 2-deoxyglucose transport, and some growth in methocel; a remarkable increase in total cell phosphotyrosine was reported (31) . Alternatively, long-term incubation of cells with sodium orthovanadate, acting as a mitogen or leading to cell injury, may mimic changes suggestive of cell transformation. We observed no changes in CEF that were suggestive of transformation, although this may be due to the fact that our experiments involved short-term incubation of CEF with vanadate. However, our studies and those of Courtneidge (17) 
